SI-BONE Q2 FY26 net loss narrows 33.6% to $4.1 million; revenue rises 15.2% to $56 million - SIBN News | RalliesSI-BONE Q2 FY26 net loss narrows 33.6% to $4.1 million; revenue rises 15.2% to $56 million
S
SIBN• Commercial progress and outlook
- Active U.S. physicians increased 19% to 1,715; June 510(k) filing submitted for a third breakthrough spine-surgery device.
- Raised 2026 revenue outlook to $231 million-$233 million, maintaining gross margin at about 79%.
Q2 results improve as revenue and profitability rise
- SI-BONE Q2 2026 revenue rose 15.2% to $56 million, with U.S. revenue up 14.7% to $53.2 million.
- Net loss narrowed 33.6% to $4.1 million, or $0.09 per share.
- Non-GAAP adjusted EBITDA swung to a profit of $2.8 million from $1 million, while gross margin eased 0.3 percentage points to 79.5%.
HIT
•
